Alexion Pharmaceuticals

100 College Street, New Haven, CT 06510

100 College Street tells an engaging story of New Haven history. Though the structure on the 100 College Street plot has only stood since 2015, the narrative of the site traces back to the 19th century – a time when New Haven served as a bustling industrial hub for peoples of all races, ethnicities, and religions. Until New Haven’s renewal period under Mayor Dick Lee, this site did not properly exist as 100 College Street on the city’s map, instead standing on Factory Street among a bevy of small crossing streets typical of the industrial urban landscape. However, as time progressed into the 20th century, New Haven’s shift towards the car and the highway led to the city’s preoccupation with enabling easy accessibility for vehicular transportation into the city. Given the site’s location just off I-95 – between Downtown and The Hill, the entire area surrounding Oak Street was leveled to create space for Route 34, or the Oak Street Connector. At the edge of the Connector’s plan, the plot of land at 100 College Street thus became part of this urban project. Still, the intention to serve a public good left 100 College Street to pay urban planning’s steepest price. Ultimately, the failure and termination of Route 34 not only displaced and destroyed the economic and social dynamism of the neighborhood, but it also left the site of 100 College Street unusable and vacant for decades. Such was the history of the site until the 2014 announcement of the Downtown Crossing Project, an ongoing redevelopment initiative that aims to transform the remnants of the Oak Street Connector into both pedestrian and car-friendly space. It so happens that 100 College Street was deemed to be the first and central piece of this monumental new city project. Consequently, construction of the towering, modern building that today stands on the site began in 2013 and was completed in 2015. Alexion Pharmaceuticals, a bioscience company known for its blood disorder medication Solaris, purchased the 14-story building and declared the impressive, Elkus Manfredi-designed structure as its headquarters in 2016. Standing west of the Knights of Columbus building and north of the Yale New Haven Hospital and Yale School of Medicine, the Alexion Pharmaceuticals building represents a new phase of urban and economic growth in New Haven. With its sleek and angular glass façade, 100 College Street reflects the city’s simultaneously modern push for both business activity and neighborhood inclusion in urban development. While Alexion did announce its relocation of its headquarters to Boston in 2017, the company still plans to maintain 100 College Street as an active center for research and development. In all, while the site carries a significant if not tumultuous past, the future looks bright for 100 College Street as a potential new hub in the city of New Haven. If history is any indication, 100 College Street will continue to write the New Haven narrative.  

Current Use

Offices / Business Activities

Era

1980-Today

Architect

Elkus Manfredi

Structural Conditions

Very Good

Street Visibilities

Yes

Threats

None known

External Conditions

Very Good

Dimensions

2.42 acre lot

Style

Modernist

Neighborhood

OtherOther

Year Built

2015

Roof Types

Flat

Researcher

Sean Singleton

Street Visibilities

Yes

Owner

Alexion Pharmaceuticals

Client

Alexion Pharmaceuticals

Historic Uses


gallery
gallery
gallery
gallery
gallery
gallery
gallery
gallery
gallery
gallery
gallery
gallery
gallery
gallery
gallery

Comments

You are not logged in! Please log in to comment.